BANGKOK,March 13,2025-- Jewellery & Gem ASEAN Bangkok 2025 (JGAB 2025),scheduled to take place from April 23-26,2025,at the Queen Sirikit National Convention Center in Bangkok,is set to be the pre
SHANGHAI,March 13,2025-- BioCity Biopharmaceutics Co.,Ltd.,a clinical-stage biopharmaceutical company,today announced that it has entered into a clinical trial collaboration agreement with MSD (Merck
TAIPEI,March 13,2025-- Acer Inc. (TWSE: 2353) announced its financial results for the fourth quarter of 2024 and fiscal 2024 ended December 31. In the fourth quarter,Acer reported consolidated revenu
HONG KONG and SHANGHAI,March 13,2025--Ping An Insurance (Group) Company of China,Ltd. ("Ping An" or the "Group",HKEx: 2318 / 82318; SSE: 601318) took top spot in the Brand Finance
TAIPEI,March 13,2025-- LITEON Technology announcesits participation in MWC 2025,where it showcased results of recent energy saving testing conducted in collaboration with NTT EAST. The tests demonstra
HONG KONG,March 13,2025-- The Global Sources Hong Kong Shows,scheduled for 11–30 April,2025,at the Hong KongAsiaWorld-Expo,will kick off the prime global sourcing season for the first half of 2025. T
HONG KONG,March 13,2025-- Kerry Logistics Network Limited (\'KLN\'; Stock Code 0636.HK),through its subsidiary,Kerry Pharma,and Teva Pharmaceutical Hong Kong Limited (\'Teva\') entered into an exclusi
BANGKOK,March 13,2025-- Thailand\'s Commission on the National Competitiveness Enhancement for Targeted Industries,at a meeting today,approved an investment by a unit of China\'sSunwoda Electronic wor
SEOUL,South Korea,Dec. 18,2024-- HyundaiMobis (KRX 012330) announced on 18th that it has developed a new battery cell cooling material to prevent battery overheating during ultra-fast charging of ele
SHANGHAI,Dec. 18,2024-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm
Highlights:
IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001
ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis
YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme
ARMONK,N.Y.,Dec. 13,2024-- The IBM (NYSE: IBM) Institute for Business Value today published its latest \'Automotive 2035\' study which reveals an industry grappling with an erratic transition away fro
BOLE,China,Dec. 13,2024-- "Device status is normal,and the one-key control operation has been completed." On December 12,the monitoring personnel of the State Grid Bortala Power Supply Compa
DUBAI,UAE,Dec. 13,2024-- Huawei unveiled the latest generation of their Mate series foldables,HUAWEI Mate X6 – an all-rounded and advanced smartphone that brings significant upgrades to display,camer
